Form 4: BeOne Medicines GC Sells Shares Under 10b5-1 Plan

BeOne Medicines' SVP and General Counsel, Lee Chan Henry, executed pre-scheduled sales of American Depositary Shares and exercised stock options on December 10 and 11, 2025.

Summary

• SVP and General Counsel, Lee Chan Henry, engaged in transactions involving BeOne Medicines Ltd. equity securities on December 10 and 11, 2025.
• On both December 10 and 11, 2025, 332 American Depositary Shares (ADS) were acquired through the exercise of derivative securities and subsequently disposed of.
• The disposition of 332 ADSs on December 10, 2025, occurred at a price of $318.28 per ADS, resulting in 0 ADSs beneficially owned directly afterward.
• The disposition of 332 ADSs on December 11, 2025, occurred at a price of $325 per ADS, resulting in 0 ADSs beneficially owned directly afterward.
• These sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025.
• On December 10, 2025, options to acquire a total of 4,316 Ordinary Shares were exercised at strike prices of $14.96, $16.41, and $12.23.
• On December 11, 2025, options to acquire a total of 4,316 Ordinary Shares were exercised at strike prices of $14.96, $16.41, and $12.23.
• Each American Depositary Share represents 13 Ordinary Shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an executive selling shares can be seen negatively, the fact that it's part of a pre-scheduled 10b5-1 plan mitigates concerns about opportunistic selling. The exercise of options indicates the executive is realizing value from their compensation.

Positives

• The exercise of stock options indicates the reporting person is realizing value from their compensation package.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned, rather than reactive, sale.

Negatives

• The disposition of American Depositary Shares by a senior executive could be perceived negatively by some investors, although it was pre-scheduled.
• The reporting person's direct beneficial ownership of American Depositary Shares was reduced to zero after each day's transactions.

Related Party Transactions

• SVP, General Counsel Lee Chan Henry engaged in the acquisition and disposition of American Depositary Shares and the exercise of stock options of BeOne Medicines Ltd., which are transactions between an insider and the company/market.

Stakeholder Impact

• Shareholders may view the executive's sale of shares with mixed sentiment, potentially interpreting it as a lack of confidence, though the 10b5-1 plan mitigates this. The exercise of options is a standard part of executive compensation and value realization.

Key Dates

Recommendation

The filing details routine insider transactions by a senior executive under a pre-established 10b5-1 trading plan. These transactions, involving the exercise of options and subsequent sale of shares, are generally not indicative of new material information about the company's prospects. Therefore, this filing alone does not provide a basis for a change in investment recommendation; a 'hold' stance is maintained pending further fundamental analysis.

Keywords

BeOne Medicines, ONC, SEC Form 4, Insider Trading, Stock Options, American Depositary Shares, ADS, Rule 10b5-1, Executive Compensation, Lee Chan Henry, SVP General Counsel